-
1
-
-
73349117506
-
Bone marrow fibrosis and diagnosis of essential thrombocythemia
-
Thiele J, Kvasnicka HM, Vardiman JW, et al: Bone marrow fibrosis and diagnosis of essential thrombocythemia. J Clin Oncol 27:e220-e221, 2009
-
(2009)
J Clin Oncol
, vol.27
-
-
Thiele, J.1
Kvasnicka, H.M.2
Vardiman, J.W.3
-
2
-
-
67649933816
-
Reticulin accumulation in essential thrombocythemia: Prognostic significance and relationship to therapy
-
Campbell PJ, Bareford D, Erber WN, et al: Reticulin accumulation in essential thrombocythemia: Prognostic significance and relationship to therapy. J Clin Oncol 27:2991-2999, 2009
-
(2009)
J Clin Oncol
, vol.27
, pp. 2991-2999
-
-
Campbell, P.J.1
Bareford, D.2
Erber, W.N.3
-
3
-
-
70349256226
-
The 2008 revision of the WHO classification of myeloid neoplasms and acute leukemia: Rationale and important changes
-
Vardiman JW, Thiele J, Arber DA, et al: The 2008 revision of the WHO classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood 114:937-951, 2009
-
(2009)
Blood
, vol.114
, pp. 937-951
-
-
Vardiman, J.W.1
Thiele, J.2
Arber, D.A.3
-
4
-
-
21444434751
-
Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia
-
Harrison CN, Campbell PJ, Buck G, et al: Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med 353:33-45, 2005
-
(2005)
N Engl J Med
, vol.353
, pp. 33-45
-
-
Harrison, C.N.1
Campbell, P.J.2
Buck, G.3
-
5
-
-
28244442441
-
Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: A prospective study
-
Campbell PJ, Scott LM, Buck G, et al: Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: A prospective study. Lancet 366:1945-1953, 2005
-
(2005)
Lancet
, vol.366
, pp. 1945-1953
-
-
Campbell, P.J.1
Scott, L.M.2
Buck, G.3
-
6
-
-
33644826144
-
The presence of the JAK2 V617F mutation is associated with a higher haemoglobin and increased risk of thrombosis in essential thrombocythaemia
-
Cheung B, Radia D, Pantelidis P, et al: The presence of the JAK2 V617F mutation is associated with a higher haemoglobin and increased risk of thrombosis in essential thrombocythaemia. Br J Haematol 132:244-245, 2006
-
(2006)
Br J Haematol
, vol.132
, pp. 244-245
-
-
Cheung, B.1
Radia, D.2
Pantelidis, P.3
-
7
-
-
27144443646
-
Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
-
Antonioli E, Guglielmelli P, Pancrazzi A, et al: Clinical implications of the JAK2 V617F mutation in essential thrombocythemia. Leukemia 19:1847-1849, 2005
-
(2005)
Leukemia
, vol.19
, pp. 1847-1849
-
-
Antonioli, E.1
Guglielmelli, P.2
Pancrazzi, A.3
-
8
-
-
27744606173
-
JAK2 mutation in essential thrombocythaemia: Clinical associations and long-term prognostic relevance
-
Wolanskyj AP, Lasho TL, Schwager SM, et al: JAK2 mutation in essential thrombocythaemia: Clinical associations and long-term prognostic relevance. Br J Haematol 131:208-213, 2005
-
(2005)
Br J Haematol
, vol.131
, pp. 208-213
-
-
Wolanskyj, A.P.1
Lasho, T.L.2
Schwager, S.M.3
-
9
-
-
38049188368
-
Bone marrow pathology in essential thrombocythemia: Interobserver reliability and utility for identifying disease subtypes
-
Wilkins BS, Erber WN, Bareford D, et al: Bone marrow pathology in essential thrombocythemia: Interobserver reliability and utility for identifying disease subtypes. Blood 111:60-70, 2008
-
(2008)
Blood
, vol.111
, pp. 60-70
-
-
Wilkins, B.S.1
Erber, W.N.2
Bareford, D.3
-
10
-
-
33845436745
-
The myeloproliferative disorders
-
Campbell PJ, Green AR: The myeloproliferative disorders. N Engl J Med 355:2452-2466, 2006
-
(2006)
N Engl J Med
, vol.355
, pp. 2452-2466
-
-
Campbell, P.J.1
Green, A.R.2
|